Cerevel Therapeutics Hldng I shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.6M | 85k | 42.40 |
| 2023-09-30 | $1.5M | 71k | 21.83 |
| 2023-06-30 | $1.5M | 61k | 24.39 |
| 2023-03-31 | $1.5M | 61k | 24.39 |
| 2022-12-31 | $1.6M | 51k | 31.54 |
| 2022-09-30 | $1.4M | 50k | 28.26 |
| 2022-06-30 | $1.6M | 62k | 26.44 |
| 2022-03-31 | $1.2M | 34k | 35.01 |
| 2021-12-31 | $1.1M | 34k | 32.42 |
| 2021-09-30 | $982k | 33k | 29.50 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas